A detailed history of Guerra Advisors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Guerra Advisors Inc holds 4,012 shares of LLY stock, worth $4.1 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares
4,012
Previous 2,742 46.32%
Holding current value
$4.1 Million
Previous $2.14 Billion 43.2%
% of portfolio
1.13%
Previous 1.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$625.65 - $812.69 $794,575 - $1.03 Million
1,270 Added 46.32%
4,012 $3.06 Billion
Q2 2025

Aug 12, 2025

BUY
$713.71 - $898.95 $401,105 - $505,209
562 Added 25.78%
2,742 $2.14 Billion
Q1 2025

Apr 25, 2025

BUY
$725.72 - $929.72 $416,563 - $533,659
574 Added 35.74%
2,180 $1.8 Billion
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $1.17 Million - $1.5 Million
1,606 New
1,606 $1.24 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Guerra Advisors Inc Portfolio

Follow Guerra Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guerra Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guerra Advisors Inc with notifications on news.